CONMED
CNMD
142 hedge funds and large institutions have $1.25B invested in CONMED in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 15 closing their positions.
227% more call options, than puts
Call options by funds: $768K | Put options by funds: $235K
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
1% more capital invested
Capital invested by funds: $1.24B → $1.25B (+$10.2M)
0.2% more ownership
Funds ownership: 100.61% → 100.81% (+0.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 48
3% less funds holding
Funds holding: 147 → 142 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$135M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.6M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$10.5M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$10.5M |
| 5 |
EIP
Epoch Investment Partners
New York
|
+$9.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$33.1M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$14.6M |
| 3 |
HCM
Huber Capital Management
El Segundo,
California
|
-$8.5M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$7.21M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.35M |
CNMD Hedge Fund Activity: Q1 2017 in Review
142 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2017, worth a combined $1.25B — up 0.83% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CNMD positions and 15 closed out — a net gain of 2 holders — while 47 added to existing stakes and 48 trimmed.
The largest buyer was BlackRock, adding an estimated $135M. The largest seller was Camber Capital Management, exiting entirely with an estimated $33.1M sold.
- 142 institutional investors held CONMED (CNMD) as of Q1 2017, down from 147 in Q4 2016.
- Funds reported $1.25B of CONMED stock for Q1 2017, up 0.83% quarter-over-quarter.
- 17 funds opened new CONMED positions in Q1 2017 and 15 closed out, a net change of +2 holders.
- The largest CONMED buyer in Q1 2017 was BlackRock, an estimated $135M added.
- The largest CONMED seller in Q1 2017 was Camber Capital Management, an estimated $33.1M sold.
Based on aggregated 13F filings for Q1 2017.